Literature DB >> 7696095

T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome.

R Topaloğlu1, U Saatçi, M Arikan, H Canpinar, A Bakkaloğlu, E Kansu.   

Abstract

This study was designed to investigate T-lymphocyte subsets interleukin-2 receptor (IL-2R) expression and IL-2 production in minimal change nephrotic syndrome (MCNS). Peripheral blood T-lymphocytes and IL-2R expression were analysed using fluorescein isothiocyanate-labelled CD3, CD4, CD8 and CD25 monoclonal antibodies with flow cytometry. IL-2 production was determined by enzyme immunoassay. Ten children with MCNS in relapse and in remission were evaluated. Thirteen healthy children served as controls. The patients in relapse demonstrated a moderate decrease in the total absolute lymphocyte counts and CD8(+) T-lymphocytes compared with controls (P < 0.05) and had a greatly increased IL-2R expression in freshly isolated, unstimulated peripheral lymphocytes compared with patients in remission and controls. While this was not statistically significant, IL-2R expression on cultured lymphocytes stimulated with phytohaemagglutinin was significantly elevated in relapse compared with those in remission and controls (P < 0.05). IL-2 production did not correlate well with IL-2R expression and there was no significant difference between the groups. Our results suggest that T-cell subset changes and high IL-2R expression on peripheral lymphocytes may indicate the presence of stimulated T-cell populations in MCNS which could contribute to the immunopathogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696095     DOI: 10.1007/bf00869075

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

Review 1.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

2.  Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy.

Authors:  K N Lai; F M Lai; S H Chui; Y M Chan; G S Tsao; K N Leung; C W Lam
Journal:  Clin Nephrol       Date:  1987-12       Impact factor: 0.975

3.  T cell subset alterations in idiopathic glomerulonephritis.

Authors:  L Cagnoli; P Tabacchi; S Pasquali; M Cenci; M Sasdelli; P Zucchelli
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

4.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

5.  T-lymphocyte activation in IgA nephropathy: serum-soluble interleukin 2 receptor level, interleukin 2 production, and interleukin 2 receptor expression by cultured lymphocytes.

Authors:  K N Lai; J C Leung; F M Lai; J S Tam
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

6.  Acquired defect in interleukin-2 production in patients with type I diabetes mellitus.

Authors:  W A Kaye; M N Adri; J S Soeldner; S L Rabinowe; A Kaldany; C R Kahn; B Bistrian; S Srikanta; O P Ganda; G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

7.  Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.

Authors:  H G Herrod; F B Stapleton; R L Trouy; S Roy
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture.

Authors:  T A Luger; J S Smolen; T M Chused; A D Steinberg; J J Oppenheim
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes.

Authors:  S C Meuer; R E Hussey; A C Penta; K A Fitzgerald; B M Stadler; S F Schlossman; E L Reinherz
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

10.  In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.

Authors:  K N Lai; J C Leung; F M Lai
Journal:  Clin Nephrol       Date:  1988-12       Impact factor: 0.975

View more
  9 in total

1.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

Review 2.  Treatment of steroid sensitive nephrotic syndrome.

Authors:  A S Abeyagunawardena
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

Review 3.  Genetics of childhood steroid-sensitive nephrotic syndrome.

Authors:  Alana M Karp; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2016-07-29       Impact factor: 3.714

4.  Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome.

Authors:  Christian Plank; Iris Ostreicher; Katalin Dittrich; Rüdiger Waldherr; Manfred Voigt; Kerstin Amann; Wolfgang Rascher; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

5.  The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.

Authors:  Asiri S Abeyagunawardena; Michael J Dillon; Lesley Rees; William van't Hoff; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

Review 6.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08

7.  Apoptosis and antioxidant defense in the nephrotic syndrome.

Authors:  Jacek Zachwieja; Waldemar Bobkowski; Marcin Zaniew; Agnieszka Dobrowolska-Zachwieja; Maria Lewandowska-Stachowiak; Aldona Siwińska
Journal:  Pediatr Nephrol       Date:  2003-09-05       Impact factor: 3.714

Review 8.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

9.  New Onset Biopsy-Proven Nephropathies after COVID Vaccination.

Authors:  Roberta Fenoglio; Stefania Lalloni; Martina Marchisio; Valentina Oddone; Emanuele De Simone; Giulio Del Vecchio; Savino Sciascia; Dario Roccatello
Journal:  Am J Nephrol       Date:  2022-03-30       Impact factor: 4.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.